Agarwal Sunil
- SEC CIK
- 0001616640
No open-market purchases or sales filed in the past year.
Current role at each company
- ATXS Astria Therapeutics, Inc.Directoras of Jan 23, 2026
- ARVN Arvinas, Inc.Directoras of Jun 30, 2025
- CALA Calithera Biosciences, Inc.Directoras of Jun 3, 2022
- SANA Sana Biotechnology, Inc.EVP, Head of Development & CMOas of Mar 8, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Agarwal Sunil as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SANA Sana Biotechnology, Inc.
EVP, Head of Development & CMO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 (view filing) | Sep 15-16 | 2 days | Agarwal SunilEVP, Head of Development & CMO | SSale | −60.0K | $26.07 | −$1.56M | −3.7%1.55M after | 2 lots |